BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24759631)

  • 1. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C; Steinkasserer A; Voll RE; Zinser E
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
    Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
    Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice.
    Stirzaker RA; Biswas PS; Gupta S; Song L; Bhagat G; Pernis AB
    Lupus; 2012 May; 21(6):656-61. PubMed ID: 22345122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
    Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
    Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
    Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
    Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
    J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.